 |
Corporate News
05-Dec-22
|
|
|
|
|
|
|
|
|
|
|
|
Biocon Biologics elevates Shreehas Tambe as MD and CEO
|
|
|
|
|
|
|
|
Biocon Biologics (BBL), a subsidiary of Biocon, announced today that Shreehas Tambe, Deputy CEO of Biocon Biologics, has been appointed as the Managing Director and CEO of the Company from 05 December 2022. Tambe will lead BBL in realizing its goal of being a global biosimilars leader.
Tambe takes over from Dr Arun Chandavarkar, who will continue to serve as a non-Executive, non-Independent Director on the Board of Biocon Biologics.
|
|
|
|
Previous News |
Sensex spurts 901 pts; Nifty above 22,400; European mkt opens higher
(
Market Commentary
-
Mid-Session
28-Mar-24
13:36
)
|
|
|
Biocon reports consolidated net profit of Rs 660.00 crore in the December 2023 quarter
(
Results
-
Announcements
09-Feb-24
07:41
)
|
|
|
Biocon gets US FDA nod for fungal infection drug
(
Hot Pursuit
-
04-Jun-24
11:18
)
|
|
|
Biocon to declare Quarterly Result
(
Corporate News
-
11-Jan-24
11:42
)
|
|
|
Biocon CFO resigns
(
Corporate News
-
08-Feb-24
19:43
)
|
|
|
Biocon Ltd soars 3.74%, rises for third straight session
(
Hot Pursuit
-
02-Jan-24
13:05
)
|
|
|
Biocon Ltd rises for third consecutive session
(
Hot Pursuit
-
24-Apr-24
13:05
)
|
|
|
Biocon slips after reporting net loss of Rs 42 cr in Q3
(
Hot Pursuit
-
15-Feb-23
11:58
)
|
|
|
Biocon redeems commercial papers worth Rs 2,250 crore
(
Hot Pursuit
-
23-Feb-23
11:50
)
|
|
|
Biocon Ltd soars 1.18%, Gains for third straight session
(
Hot Pursuit
-
26-Dec-23
13:05
)
|
|
|
Biocon to declare Quarterly Result
(
Corporate News
-
10-Oct-23
11:29
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|